207 related articles for article (PubMed ID: 19822494)
41. Hepatocyte-specific activation of NF-kappaB does not aggravate chemical hepatocarcinogenesis in transgenic mice.
Yau TO; Chan CF; Gee-San Lam S; Cheung OF; Ching YP; Jin DY; Sham MH; Ng IO
J Pathol; 2009 Feb; 217(3):353-61. PubMed ID: 19090486
[TBL] [Abstract][Full Text] [Related]
42. Activation of TLR-4 and liver injury via NF-kappa B in rat with acute cholangitis.
Yu H; Wu SD
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):185-91. PubMed ID: 18397856
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic effect of dimethyl sulfoxide on ICAM-1 gene expression and activation of NF-kappaB and AP-1 in septic rats.
Chang CK; Albarillo MV; Schumer W
J Surg Res; 2001 Feb; 95(2):181-7. PubMed ID: 11162043
[TBL] [Abstract][Full Text] [Related]
44. [Inhibition of nuclear factor kappa B attenuates multiple organ injury following ruptured abdominal aortic aneurysm: an experiment with rats].
Yang J; Hu XH; Liu CW; Zhang ZS; Li TM; Yang DH; Zhang Q
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):237-41. PubMed ID: 16677502
[TBL] [Abstract][Full Text] [Related]
45. Induction of Mdr1b expression by tumor necrosis factor-alpha in rat liver cells is independent of p53 but requires NF-kappaB signaling.
Ros JE; Schuetz JD; Geuken M; Streetz K; Moshage H; Kuipers F; Manns MP; Jansen PL; Trautwein C; Müller M
Hepatology; 2001 Jun; 33(6):1425-31. PubMed ID: 11391531
[TBL] [Abstract][Full Text] [Related]
46. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.
Németh J; Stein I; Haag D; Riehl A; Longerich T; Horwitz E; Breuhahn K; Gebhardt C; Schirmacher P; Hahn M; Ben-Neriah Y; Pikarsky E; Angel P; Hess J
Hepatology; 2009 Oct; 50(4):1251-62. PubMed ID: 19670424
[TBL] [Abstract][Full Text] [Related]
47. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
48. [Inhibitory effects of intervention of the TNFa/NF-kappaB signaling pathway activation on hepatoma cell proliferation].
Gu X; Yao M; Wang S; Shi Y; Dong Z; Qiu L; Yao D
Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):434-9. PubMed ID: 25203707
[TBL] [Abstract][Full Text] [Related]
49. [Effects of glutamine on changes of nuclear factor-kappa B in acute lipopolysaccharide lung injury: experiment with rats].
Chen XG; Bai T; Wu BY; Wang JK
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1648-50. PubMed ID: 19035109
[TBL] [Abstract][Full Text] [Related]
50. [Glutamine inhibits interleukin-1beta induced nitric oxide production and inducible nitric oxide synthase expression: experiment with cultured rat hepatocytes].
Lu J; Wang XY; Tang WH
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):695-8. PubMed ID: 19595066
[TBL] [Abstract][Full Text] [Related]
51. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
52. [The effect of thalidomine-induced NF-kappa B activation on malignant transformation of hepatocytes].
Yao DF; Yu HB; Shen JJ; Wang YL; Wu XH; Qiu LW; Wu W
Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):312-4. PubMed ID: 19403036
[No Abstract] [Full Text] [Related]
53. Intrinsic apoptosis and NF-κB signaling are potential molecular targets for chemoprevention by black tea polyphenols in HepG2 cells in vitro and in a rat hepatocarcinogenesis model in vivo.
Murugan RS; Priyadarsini RV; Ramalingam K; Hara Y; Karunagaran D; Nagini S
Food Chem Toxicol; 2010 Nov; 48(11):3281-7. PubMed ID: 20828598
[TBL] [Abstract][Full Text] [Related]
54. [The association of abnormal activation of hepatocyte nuclear factor-kappa B with hepatocarcinogenesis].
Yao DF; Su XQ
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):539-40. PubMed ID: 16867281
[No Abstract] [Full Text] [Related]
55. Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.
Schattenberg JM; Schuchmann M; Galle PR
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():213-9. PubMed ID: 21199533
[TBL] [Abstract][Full Text] [Related]
56. MicroRNA-657 promotes tumorigenesis in hepatocellular carcinoma by targeting transducin-like enhancer protein 1 through nuclear factor kappa B pathways.
Zhang L; Yang L; Liu X; Chen W; Chang L; Chen L; Loera S; Chu P; Huang WC; Liu YR; Yen Y
Hepatology; 2013 May; 57(5):1919-30. PubMed ID: 23175432
[TBL] [Abstract][Full Text] [Related]
57. The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways.
Bar-Yehuda S; Stemmer SM; Madi L; Castel D; Ochaion A; Cohen S; Barer F; Zabutti A; Perez-Liz G; Del Valle L; Fishman P
Int J Oncol; 2008 Aug; 33(2):287-95. PubMed ID: 18636149
[TBL] [Abstract][Full Text] [Related]
58. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis.
Bishayee A; Thoppil RJ; Darvesh AS; Ohanyan V; Meszaros JG; Bhatia D
J Nutr Biochem; 2013 Jan; 24(1):178-87. PubMed ID: 22841394
[TBL] [Abstract][Full Text] [Related]
59. [Expression features of glypican-3 and its diagnostic and differential values in hepatocellular carcinoma].
Bian YZ; Yao DF; Zhang CG; Li SS; Wu W; Dong ZZ; Qiu LW; Yu DD
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):260-5. PubMed ID: 21586223
[TBL] [Abstract][Full Text] [Related]
60. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
